OCBCO
ABBV icon

Oversea-Chinese Banking Corp (OCBC)’s AbbVie ABBV Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Sell
13,597
-840
-6% -$181K 0.07% 165
2026
Q1 		$3.14M Buy
14,437
+13,367
+1,249% +$2.97M 0.08% 157
2025
Q4 		$244K Sell
1,070
-1,892
-64% -$431K 0.01% 308
2025
Q3 		$686K Buy
2,962
+1,070
+57% +$218K 0.02% 235
2025
Q2 		$351K Sell
1,892
-3,795
-67% -$705K 0.01% 279
2025
Q1 		$1.19M Buy
5,687
+1,978
+53% +$385K 0.03% 217
2024
Q4 		$659K Sell
3,709
-5,208
-58% -$958K 0.02% 260
2024
Q3 		$1.75M Buy
8,917
+4,217
+90% +$787K 0.05% 188
2024
Q2 		$806K Buy
4,700
+1,920
+69% +$318K 0.02% 244
2024
Q1 		$506K Sell
2,780
-6,827
-71% -$1.18M 0.02% 287
2023
Q4 		$1.49M Buy
9,607
+1,045
+12% +$152K 0.05% 158
2023
Q3 		$1.28M Buy
8,562
+6,427
+301% +$943K 0.06% 176
2023
Q2 		$288K Sell
2,135
-9,215
-81% -$1.35M 0.01% 279
2023
Q1 		$1.81M Buy
11,350
+7,574
+201% +$1.16M 0.09% 142
2022
Q4 		$610K Buy
+3,776
New +$579K 0.04% 203

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s ABBV Position: Q2 2026 in Review

Oversea-Chinese Banking Corp (OCBC) reduced its AbbVie (ABBV) stake by 5.8% in Q2 2026, selling an estimated $181K and leaving 13,597 shares worth $3.42M. The position accounts for 0.07% of the portfolio, ranked #165.

Oversea-Chinese Banking Corp (OCBC) first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 13,597 shares of AbbVie worth $3.42M as of Q2 2026.
  • Oversea-Chinese Banking Corp (OCBC) sold 840 AbbVie shares in Q2 2026, an estimated $181K.
  • AbbVie made up 0.07% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #165 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.